The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6767571 7214103 F 6767571-1 20100601 20100614 EXP PHHY2009CA48783 NOVARTIS PHARMACEUTICAL CORPORATION YR M Y 20100614 OT CANADA

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6767571 1013857281 PS SANDOSTATIN LAR 1 INTRAMUSCULAR 40 MG, EVERY 4 WEEKS 021008

Indications of drugs used

Event ID DRUG SEQ INDI PT
6767571 1013857281 ACROMEGALY

Outcome of event

Event ID OUTC COD
6767571 HO
6767571 OT

Reactions reported

Event ID PT
6767571 INJECTION SITE HAEMORRHAGE
6767571 INTERNATIONAL NORMALISED RATIO INCREASED
6767571 PNEUMONIA

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6767571 1013857281 19970301 20070620 3764 DAY